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Background: Cartilage morphometry based on magnetic resonance images (MRIs) is an emerging outcome
measure for clinical trials among patients with knee osteoarthritis (KOA). However, current methods for cartilage
morphometry take many hours per knee and require extensive training on the use of the associated software.
In this study we tested the feasibility, reliability, and construct validity of a novel osteoarthritis cartilage damage
quantification method (Cartilage Damage Index [CDI]) that utilizes informative locations on knee MRIs.
Methods: We selected 102 knee MRIs from the Osteoarthritis Initiative that represented a range of KOA structural
severity (Kellgren Lawrence [KL] Grade 0 – 4). We tested the intra- and inter-tester reliability of the CDI and
compared the CDI scores against different measures of severity (radiographic joint space narrowing [JSN] grade,
KL score, joint space width [JSW]) and static knee alignment, both cross-sectionally and longitudinally.
Results: Determination of the CDI took on average14.4 minutes (s.d. 2.1) per knee pair (baseline and follow-up
of one knee). Repeatability was good (intra- and inter-tester reliability: intraclass correlation coefficient >0.86). The
mean CDI scores related to all four measures of osteoarthritis severity (JSN grade, KL score, JSW, and knee alignment;
all p values < 0.05). Baseline JSN grade and knee alignment also predicted subsequent 24-month longitudinal change
in the CDI (p trends <0.05). During 24 months, knees with worsening in JSN or KL grade (i.e. progressors) had greater
change in CDI score.
Conclusions: The CDI is a novel knee cartilage quantification method that is rapid, reliable, and has construct validity for
assessment of medial tibiofemoral osteoarthritis structural severity and its progression. It has the potential to addresses
the barriers inherent to studies requiring assessment of cartilage damage on large numbers of knees, and as a biomarker
for knee osteoarthritis progression.
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Measurement of hyaline cartilage damage is viewed as a
primary endpoint in the assessment of structural progres-
sion of knee osteoarthritis (OA). However, the traditional
radiographic measurement approach provides only indirect
visualization of cartilage and is limited by poor reproduci-
bility and sensitivity to change [1]. Magnetic resonance
(MR) imaging is a noninvasive technology that can generate* Correspondence: tmcalindon@tuftsmedicalcenter.org
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unless otherwise stated.3-dimensional images of intra-articular soft-tissue struc-
tures, including hyaline cartilage. Quantification of knee
cartilage morphology (e.g., thickness, volume) is highly reli-
able and provides potential surrogate endpoints for epide-
miologic studies and clinical trials of interventions with
potential for structure modification [2-6]. However, the
process of measuring cartilage morphology on MR images
is time-consuming and burdensome. Each 3-dimensional
(3D) knee MR sequence may take many hours for a reader
to manually segment. Furthermore, operators who use car-
tilage segmentation software often need extensive training
[7] which further contributes to the time and cost.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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eral approaches to reduce the burden of measuring knee
cartilage on MR images. These have included segment-
ing alternate MR slices or confining measurements to
partial regions of cartilage [8-10]. Computer-aided algo-
rithms (e.g., active contours, B-splines) have also been
developed to assist with cartilage segmentation [11-15].
Unfortunately, these methods lack sufficient accuracy
and reliability to detect small cartilage changes [2]. Thus,
there remains a need among researchers for a quantifica-
tion method that can be rapidly computed and has good
reproducibility, validity, and sensitivity to change.
The work in this paper is motivated by the observation
that some articular cartilage locations are more susceptible
to occurrence of OA damage and thus may be more in-
formative in the measurement of its progression [16,17].
Thus, focusing effort on measuring these locations in a
reproducible manner may improve the efficiency and sensi-
tivity to change. Therefore, the goal of this study was to de-
velop an efficient cartilage quantification method leveraging
informative locations in the medial tibia and femur, and
to test its reliability, construct validity, and sensitivity to
change. We focused on the medial tibiofemoral com-
partment because medial OA is more common than
lateral OA [18,19].
Methods
Rapid knee cartilage damage index quantification method
We developed a rapid knee cartilage damage quantifica-
tion method using knee MR images from three datasets
(263 knees). Underlying this methodology is a 2-
dimensional, rectangular, universal coordinate systems
to represent the articular surface of the distal femur and
proximal tibia. Using previously manually segmented kneesFigure 1 3D medial cartilage images with 9 informative locations on
rotated for better viewing informative locations).[20], we projected the denuded cartilage area on our
coordinate system to identify the areas in the joint sur-
face that are most frequently denuded of cartilage.
Based on the results of that analysis, we then selected
nine locations within the region of the most commonly
denuded areas on the medial femur and tibia (Figure 1).
A full description of the developmental methodology
and related data is provided in the Additional file 1.
Validation dataset
For this validation study we used data and MR images from
the Osteoarthritis Initiative (OAI), which was initiated to
promote the evaluation of OA biomarkers as potential
surrogate endpoints [4]. The OAI has institutional review
board approval (IRB) from the coordinating centers and the
four clinical centers (University of Maryland and John’s
Hopkins comprise a single recruitment center, Brown Uni-
versity, Ohio State University, University of Pittsburgh). All
participants provided informed consent to participate in
the OAI. The four OAI clinical centers recruited approxi-
mately 4800 men and women (ages 45–79 years) with or at
risk for knee OA. The OAI participants had weight-bearing
posterior-anterior fixed-flexion knee radiographs obtained
at the baseline and 24-month visits. We obtained a con-
venience sample of 102 pairs of knee (baseline and
24-month MR scans) not included in our developmental
datasets that had complete data (i.e., clinical, static
knee alignment, semi-quantitative radiographic grad-
ing, and joint space width). We selected our sample
to represent the range of radiographic OA severity
(Kellgren-Lawrence [KL] scores 0 to 4) enriched with
knees that showed radiographic worsening over time.
We randomly selected 40 knees with KL = 2, among
whom 20 knees had worsening of their KL grade overfemur and 9 informative locations on tibia (the 3D images were
Figure 2 CDI measurement of the medial tibiofemoral
compartment.
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domly included 35 knees with KL = 3, among whom 15
knees increased KL grade over 24 months and 20 knees
did not change. We included all of the knees with KL
grades 0, 1, and 4 that had complete data and were not
included in our developmental datasets.
MR image assessments
Our validation analyses used the OAI 3D sagittal water-
excitation dual-echo steady state (DESS) images with field
of view = 140 mm, slice thickness = 0.7 mm, skip = 0 mm,
flip angle = 25 degrees, echo time = 4.7 ms, recovery time =
16.3 ms, 307 × 384 matrix, phase encode ant/post. X reso-
lution = 0.365 mm, and y resolution = 0.456 mm. All OAI
images were obtained using one of four identical Siemens
Trio 3-Tesla MR systems and a USA Instruments quadra-
ture transmit-receive knee coil at one of four OAI clinical
sites [21]. The OAI MR images are publicly available upon
request at http://oai.epi-ucsf.org.
Measurement of cartilage damage on MR images
One investigator (MZ), who was blinded to the outcome
measures, performed the CDI measurement on paired
baseline and 24-month follow-up MR images. The inves-
tigator was not blinded to the order of images (baseline
or follow-up). The investigator used customized software
to (1) translate an articular surface into a 2-dimensional
coordinate matrix, (2) localize 9 pre-defined informative
locations (characterized by a greater propensity to ex-
hibit cartilage loss), and (3) measure cartilage thickness
at those locations (Figure 1). To co-locate the corre-
sponding informative locations on baseline and follow-
up images, we used dual screens to permit simultaneous
visual comparison of the MR image sets.
In the first step the reader indicated the most medial and
lateral MR image slices within the knee. These images des-
ignated the minimum and maximum values of the medial-
to-lateral axis on the 2-dimensional coordinate system.
Next, the software automatically determined the MR image
slices that contained the informative locations. On each of
these slices the investigator manually traced the bone-
cartilage boundary using predefined segmentation rules.
The software then translated the length of the bone-
cartilage boundary to a standardized anterior-to-posterior
axis and indicated the predefined informative locations so
that the investigator could measure the cartilage thickness
at those points (Figure 2). The software then computed the
cartilage damage index (CDI) by summing the products of
cartilage thickness, cartilage length (anterior-posterior), and
voxel size from each informative location.
Assessment of reliability
To evaluate the intra- and inter-tester reliability we se-
lected 20 pairs of knees (baseline and follow-up MRscans) representative of a full range of disease severity in
the sample. Two investigators (MZ and DH) independ-
ently measured the CDI on two occasions, separated by
at least 72 hours. We evaluated intra-tester and inter-
tester reliability with intraclass correlation coefficients
(ICC) [22]. Specifically, we used an ICC 3,1 model for
intra-tester reliability and an ICC 2,1 model for inter-
tester reliability. To explore if the reliability was consist-
ent across levels of OA severity we conducted secondary
analyses to explore ICCs among knees with no-mild
medial joint space narrowing (JSN; medial JSN score = 0
or 1; n = 13) and more severe medial JSN (JSN score = 2
or 3; n = 7). We selected this JSN cut-point because it
provided a sufficient sample size in each group to esti-
mate ICCs.
Assessment of measurement time
We recorded the measurement time for 20 pairs of
knees (baseline and follow-up MR scans) and calculated
the mean and standard deviation time to measure the 20
knees. The investigator started the timer when he started
to load the MR images and stopped the timer after sav-
ing the quantification data.
Radiographic assessments
To assess construct validity of the CDI we compared it
with three radiographic measures of knee OA (JSN, KL
grade, and JSW), that have been extensively reported in
the past to be associated with cartilage damage [23-27].
The semi-quantitative and quantitative knee radio-
graphic measurements have been previously described in
detail [6,28-30]. Briefly, semi-quantitative assessments of
radiographic knee OA severity were performed using the
weight-bearing posterior-anterior fixed-flexion knee radio-
graphs from the baseline and 24-month OAI visit. The
Table 1 Descriptive characteristics of validation dataset
(n = 102)
Age, mean (SD) years 61.61 (8.74)
Female, n (%) 56 (54.37)
JSN grade, n (%) Baseline 24-month follow-up
0 43 (42.16) 42 (41.18)
1 31 (30.39) 25 (24.51)
2 25 (24.51) 20 (19.61)
3 3 (2.94) 15 (14.71)
KL score, n (%) Baseline 24-month follow-up
0 4 (3.92) 3 (2.94)
1 19 (18.63) 15 (14.71)
2 40 (39.22) 25 (24.51)
3 34 (33.33) 40 (39.22)
4 5 (4.90) 19 (18.63)
Note: n = number; SD = standard derivation; JSN = joint space narrowing;
KL = Kellgren-Lawrence.
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for KL grade and modified OARSI-atlas based assessment
of medial JSN scores (0 to 3), which defined definite pro-
gression within an OARSI grade [31]. KL progression was
defined as any worsening of the KL score from 0 to
24 months. A different group performed central measure-
ments of joint space width (JSW) at fixed-locations in the
medial tibiofemoral compartment. We selected JSW at
one fixed location (x = 0.250) because it is one of the most
responsive locations for assessing JSW change [28]. These
data and descriptions of the methods are publicly available
on the OAI website (kxr_sq_bu_00 [version 0.5] and
kxr_sq_bu_03 [version 3.5], kxr_qjsw_duryea_00 [version
0.5] and kxr_qjsw_duryea_03 [version 3.4]; http://oai.epi-
ucsf.org/; ICC > 0.93).
Static alignment
To further assess construct validity of the CDI we tested its
association with static knee alignment, a well-established
risk factor for medial cartilage damage [23,27,32,33]. One
reader measured static alignment, hip-knee-ankle (HKA)
angle on standing full-limb radiographs that were collected
at either the 12- or 24-month OAI visit using a semi-
automated program (developed by Jeff Duryea, ICC > 0.99).
Analytic approach
We calculated descriptive characteristics for the sample.
To account for different skeletal sizes, we adjusted the
CDI by dividing the raw data by the participant’s height.
Change in height-adjusted CDI was calculated as follow-
up minus baseline. To explore the construct validity of
the new cartilage quantification method we tested for a
linear trend of baseline and change in CDI across higher
baseline grades of JSN and KL. Linear trend was tested
using linear regression and treating JSN and KL grades
as continuous variables. We also used independent
sample t-tests to determine if CDI change was different
between knees with and without radiographic OA progres-
sion (based on changes in JSN and KL grades). Spearman
correlations were used to assess the relationship between
baseline and change in CDI to static alignment, baseline
and 24-month change of JSW. P-values < 0.05 were con-
sidered statistically significant. To assess responsiveness
among knees with and without radiographic OA progres-
sion we calculated absolute standardized response mean
(SRM) values (SRM=mean change divided by standard de-
viation of change). All analyses were performed in SAS 9.3
(SAS Institute Inc., Cary, NC) with the exception of the
ICCs, which were performed in SPSS 19 (IBM Co., NY).
Results
Validation dataset characteristics
The descriptive characters of 102 participants are in Table 1.
There were 25 knees with medial JSN progression (differentJSN grade at baseline and follow-up) and 39 knees with KL
progression (different KL grade at baseline and follow-up).
The overall SRMs for the CDI were −0.78 in the medial
femur, −0.64 in the medial tibia, and −0.87 in the medial
tibiofemoral compartment.
Measurement time
The average CDI measurement time of 20 knees was
14.4 minutes (SD = 2.1) per pair of knees (baseline and
24 month scans).
Assessment of reliability
Intra-tester (ICC3,1) reliability for both investigators
ranged from 0.94 to 0.99. The good intra-tester reliability
was consistent among knees with no-mild medial JSN
(ICC3,1 = 0.93 to 0.99) and more severe JSN (ICC3,1 = 0.80
to 0.99). Inter-tester (ICC2,1) reliability for medial femur,
medial tibia, and total medial tibiofemoral ranged from
0.86 to 0.95. The good inter-tester reliability was consistent
among knees with no-mild medial JSN (ICC2,1 = 0.78 to
0.92) and more severe JSN (ICC2,1 = 0.87 to 0.93).
Relationship of baseline CDI to baseline radiographic severity
Medial JSN
Knees with greater JSN score (i.e. greater OA severity)
had lower mean medial femur, tibia, and tibiofemoral
CDIs (indicating more cartilage damage; Table 2, all p for
linear trend < 0.01).
JSW measurement
The baseline medial femur, tibia, and tibiofemoral CDI
scores were significantly correlated with baseline JSW
(Table 3; all p < 0.05).
Table 2 Cartilage damage index stratified by baseline medial joint space narrowing (JSN) grade
Baseline medial JSN Grade
Cartilage measure JSN = 0 (n = 43)
mean (SD)
JSN = 1 (n = 31)
mean (SD)
JSN = 2 (n = 25)
mean (SD)




Femur CDI (Baseline) 825.14 (148.42) 754.71 (125.54) 529.29 (130.35) 325.89 (324.51) <0.01
Tibia CDI (Baseline) 352.29 (72.47) 328.96 (60.91) 233.45 (68.77) 95.83 (99.73) <0.01
Tibiofemoral CDI (Baseline) 1177.40 (198.78) 1083.70 (173.17) 762.74 (183.50) 421.72 (420.65) <0.01
Longitudinal
Femur CDI (Change) −31.06 (46.40) −49.67 (61.65) −78.55 (66.81) −185.4 (170.07) <0.01
Tibia CDI (Change) −12.17 (25.16) −23.27 (33.83) −46.18 (52.46) −42.41 (41.07) <0.01
Tibiofemoral CDI (Change) −43.23 (57.65) −72.94 (76.02) −124.70 (97.47) −227.80 (208.59) <0.01
Notes: change = follow-up minus baseline; SD = standard deviation.
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There was generally a lower CDI across increasing KL,
with the exception that knees with KL grade 2 had a
greater CDI compared to those with KL grade 1 (Table 4,
all p for linear trend < 0.01).
Knee alignment
Baseline CDI was positively associated with baseline
static knee alignment (Table 3). In other words, a lower
CDI was associated with varus alignment.
Relationship of longitudinal change in CDI to baseline
radiographic severity
Medial JSN
Knees with greater baseline JSN score generally had
greater subsequent change in the CDI (reflecting greater
longitudinal cartilage loss; Table 2, all p for linear trend
< 0.01). This trend plateaued at JSN = 2 for change in
tibia CDI, but increased in a linear fashion for femur
and tibiofemoral CDI change.
KL grade
There were less pronounced linear trends of change in the




Femur CDI (Baseline) 0.34* 0.84*
Tibia CDI (Baseline) 0.21* 0.77*
Tibiofemoral CDI (Baseline) 0.31* 0.87*
HKA JSW change
Femur CDI (Change) 0.29* 0.30*
Tibia CDI (Change) 0.34* 0.40*
Tibiofemoral CDI (Change) 0.36* 0.43*
Notes: *p < 0.05; HKA =hip-knee-ankle; JSW= joint space width change = follow-up
minus baseline.There was not a statistically significant trend found for
change in tibia CDI (Table 4).
Knee alignment
There was a statistically significant relationship between
longitudinal CDI over 24 months and baseline static
alignment (Table 3); all p < 0.05, such that those with
more varus alignment had more medial cartilage damage
longitudinally.
Relationship of longitudinal change in CDI to longitudinal
change in radiographic severity
Medial JSN and KL grades
Knees with radiographic progression over the 24 month
observation period, as indicated by an increase in JSN or
KL grade, had greater change in CDI scores compared
with knees with no progression (Table 5). The SRM
values for the CDI among knees with JSN or KL change
(i.e. those with structural progression) were 12% to
300% greater than knees without JSN or KL change
(e.g., SRM = −1.39 for tibia JSN progression knees;
SRM = −0.45 for tibia JSN non-progression knees).
JSW measurement
The 24-month change of medial femur, tibia, and tibiofe-
moral CDI scores were significantly correlated with 24-
month change of JSW (Table 3; all p < 0.05)
Discussion
This study demonstrates that the MR-based CDI can be
rapidly and reliably applied in the medial tibiofemoral
compartment, and has construct validity as an aggregate
measure of cartilage damage in knee OA. The predicate
of the development of the CDI was that a focus on loca-
tions that have increased susceptibility to cartilage loss
would shorten measurement time and increase sensitiv-
ity to change [16,34], a notion that our results appear to
corroborate. As a method that can be rapidly deployed,
it offers the potential to address the current barriers that
Table 4 Cartilage damage index stratified by baseline Kellgren-Lawrence (KL) grade
Cartilage measure KL = 0 (n = 4)
mean (SD)
KL = 1 (n = 19)
mean (SD)
KL = 2 (n = 40)
mean (SD)
KL = 3 (n = 34)
mean (SD)





Femur CDI (Baseline) 771.99 (157.40) 750.75 (159.50) 781.47 (114.73) 634.00 (218.90) 583.92 (434.01) <0.01
Tibia CDI (Baseline) 363.07 (103.74) 314.96 (60.46) 343.96 (66.72) 272.83 (94.26) 199.81 (163.56) <0.01
Tibiofemoral CDI (Baseline) 1135.1 (257.41) 1065.7 (207.06) 1125.4 (155.11) 906.83 (304.59) 783.73 (595.54) <0.01
Longitudinal
Femur CDI (Change) −81.06 (46.06) −30.35 (43.25) −36.72 (59.38) −72.92 (62.13) −109.4 (159.37) 0.02
Tibia CDI (Change) −56.37 (43.48) −17.85 (32.13) −15.14 (26.74) −35.36 (49.33) −30.86 (33.75) 0.40
Tibiofemoral CDI (Change) −137.40 (80.56) −48.19 (61.81) −51.86 (69.27) −108.30 (90.93) −140.20 (190.81) 0.03
Notes: change = follow-up minus baseline; SD = standard deviation.
Zhang et al. BMC Musculoskeletal Disorders 2014, 15:264 Page 6 of 9
http://www.biomedcentral.com/1471-2474/15/264measuring OA cartilage damage on large numbers of
knee MR images. With apparently good discriminative
validity for worsening of knee OA structural severity, it
may also have usefulness as a proxy biomarker of OA
progression.
We found that the CDI can be measured in the medial
tibiofemoral compartment by a trained technician within
about 14 minutes for a pair of knee images. While future
development of the methodology will need to expand
the CDI into the lateral tibiofemoral and patellofemoral
compartments, the total measurement time will likely
remain substantially shorter than for other MR-based
cartilage measurement methods.
We tested the construct validity of the CDI by comparing
it with other established radiographic measures of knee
OA severity including medial tibiofemoral JSN (a semi-
quantitative scale), JSW (continuous), KL grade (a global
semi-quantitative score), and knee alignment. Radiographic
JSN and JSW are generally attributed to loss of articular
cartilage among knees with OA [35]. One study found that
knees with JSN = 2 and JSN= 3 have 27% and 56% less car-
tilage thickness in the central medial tibiofemoral region
compared with a contralateral knee with no JSN [23].Table 5 Change in CDI among knees with and without structu
No structural progression
n Mean SD
Femur CDI (Change) 74 −35.73 50.14
Tibia CDI (Change) 74 −10.86 23.99
Tibiofemoral CDI (Change) 74 −46.58 57.48
No structural progression
n Mean SD
Femur CDI (Change) 58 −40.53 49.84
Tibia CDI (Change) 58 −15.86 33.21
Tibiofemoral CDI (Change) 58 −56.39 64.12
Notes: Structural Progression, JSN/KL has different grade at baseline and follow- up
both of them are the highest grade, no grade change happens); SD = standard devWhile we only used 18 informative locations, our CDI de-
tected a similar trend with 35% and 64% less medial tibiofe-
moral CDI among knees with JSN = 2 and 3 (Table 2)
compared with knees without JSN. Furthermore, prior
studies have found similar correlations to ours for medial
JSW and medial tibiofemoral cartilage morphology (r = 0.46
to 0.71) [27,36,37] and changes in these measures (r = 0.21
to 0.48) [24,25]. Overall, we consistently found relationships
between the CDI and the severity of radiographic OA ex-
cept that knees with KL grade 2 had a greater baseline CDI
and less apparent progression compared with those with
KL grade 1 (i.e., suggesting less damage; Table 4). However,
others have observed that knees with KL grade 2 often have
thicker cartilage and less cartilage loss, which is attributed
it to cartilage swelling – an early feature of cartilage damage
[26,27]. Despite the CDI being based on only 18 locations,
these informative locations are sufficient to calculate a CDI
that agrees with pre-established associations between cartil-
age damage and radiographic OA severity.
In addition to verifying that the CDI was associated
with radiographic OA severity we also demonstrated
that the CDI is related to knee alignment (baseline CDI:
r = 0.21 to 0.33, CDI change: r = 0.29 to 0.36), which is aral progression
Joint Space Narrowing (JSN)
Structural progression p-value
SRM n Mean SD SRM
−0.71 25 −87.82 68.62 −1.28 <0.0001
−0.45 25 −63.83 46.02 −1.39 <0.0001
−0.81 25 −151.7 90.95 −1.67 <0.0001
Kellgren-Lawrence (KL)
Structural progression p-value
SRM n Mean SD SRM
−0.81 39 −64.06 70.06 −0.91 0.060
−0.48 39 −37.23 43.34 −0.86 0.007
−0.88 39 −101.3 96.68 −1.05 0.007
; N = number of knees (the numbers were excluded JSN = 3 and KL = 4 since
iation; SRM = standardized response mean.
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correlations are comparable to other MR-based cartilage
measures (cross-sectional r = 0.20 to 0.22; change in cartil-
age r = 0.10 to 0.40) [23,33]. These findings further support
that not only is the CDI associated with other measures of
disease severity but also an important risk factor.
In a recent meta-analysis of articular cartilage quantita-
tive assessments that provided SRMs to reflect responsive-
ness, measures of the medial tibia had SRMs that ranged
from −0.63 to −0.34, medial femur: −0.74 to −0.28, and
medial tibiofemoral: −1.26 to −0.46 [38]. The SRMs for the
CDI (Table 5) were comparable to those reported in this re-
cent systematic review. This was true even among knees
without structural progression with the exception of the
medial tibia. These findings suggest that the CDI performs
well on cartilage measurements; however, additional studies
are needed to directly compare these methods.
There are a number of limitations to our study includ-
ing that that the 3D DESS sequence in the OAI utilized
a low flip angle of 25°, which is not optimal for contrast-
ing fluid and cartilage signal [39]. However, the OAI
DESS sequence is well validated [4,40], and has been
successfully used to measure cartilage volume many
studies using traditional manual segmentation methods
[4,23,26,41-44]. Therefore, the OAI was a reasonable
data set in which to develop the CDI measurement and
it is quite possible that the CDI may perform even better
in other data sets. Another limitation to our study was
that our validation data set did not include total cartilage
segmentation values. The CDI, however, was developed
using manual cartilage segmentation (see Additional file 1)
where we found a good correlation (r > 0.60, Additional
file 1: Table S3) between baseline CDI and cartilage volume
(manual segmentation). It may be advantageous to test the
association between CDI and manual segmentation in a dif-
ferent dataset to verify that the CDI is related to cartilage
volume beyond the OAI. Another limitation was that we
did not quantify the accuracy of placing the informative
locations. We believe that the placement of informative
locations on baseline and follow-up images was accurate
because we used a robust coordinate system, trained the
reader to detect errors, found good construct validity, and
detected large measures of responsiveness. Future studies
should quantify the accuracy of placing the informative lo-
cations and strive to minimize any error since this may fur-
ther enhance the performance of the CDI. We would also
point out that at present the CDI is only applicable to the
medial tibiofemoral compartment. However, findings from
this study reinforce the need to propagate the CDI ap-
proach to the lateral tibiofemoral and patellofemoral com-
partments. Finally, a potential drawback to the CDI is the
possibility of failing to quantify cartilage damage at loca-
tions that were not identified as informative locations. This
limitation is similar to other approaches that focus onspecific regions of the articular surface (e.g., central weight-
bear medial femur) [8-10]. Despite this limitation, the CDI
performed well in these analyses, which may suggest that
only a small number of knees, if any, experience consider-
able cartilage damage in regions not covered by the inform-
ative locations.
Conclusions
In summary, this cartilage-damage quantification method,
which is based on informative locations, is relatively easy to
implement, provides reliable measurements, has good con-
struct and discriminative validity, and is sensitive to change
in the state of osteoarthritis. This method has the potential
to address the current barriers that measuring OA cartilage
damage on large numbers of knee MR images, such as the
Osteoarthritis Initiative and other large epidemiologic
investigations. Furthermore, with apparently good dis-
criminative validity for worsening of knee OA struc-
tural severity, it may also have usefulness as a proxy
biomarker of OA progression.
Additional file
Additional file 1: Development of Cartilage Damage Index.
Abbreviations
3D: 3-dimensional; CDI: Cartilage damage index; DESS: Dual-echo steady
state; HKA: Hip-knee-ankle; ICC: Intraclass correlation coefficients; JSN:
Joint space narrowing; JSW: Joint space width; KL: Kellgren Lawrence;
MR: Magnetic resonance; MRIs: Magnetic resonance images; OA: Osteoarthritis;
OAI: Osteoarthritis initiative; SD: Standard derivation; SRM: Standardized
response mean.
Competing interests
The authors have no competing interests that could potentially and
inappropriately influence this work.
Authors’ contributions
MZ participated in the conception and design of the study, acquisition of
data, analysis, interpretation of data, drafting/revisions of the article, as well
as final approval of the article. JBD participated in the conception and
design of the study, acquisition of data, analysis and interpretation of data,
drafting/revisions of the article, as well as final approval of the article. LLP
participated in the conception and design, acquisition of data, analysis,
interpretation of data, drafting/revisions of the article, as well as final
approval of the article. DH participated in intra- and inter-tester reliability test.
GHL participated in interpretation of data, drafting/revisions of the article,
as well as final approval of the article.. EM participated in the conception and
design, drafting/revisions of the article, as well as final approval of the article.
RW participated in developing the cartilage segmentation rule, drafting/revisions
of the article, as well as final approval of the article. TEM participated in the
conception and design, analysis and interpretation of data, drafting/revisions
of the article, as well as final approval of the article. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported in part by The Role of Bone in Knee Osteoarthritis
Progression (NIH/NIAMS grant 1R01AR054938). The OAI is a public-private
partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259;
N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National
Institutes of Health, a branch of the Department of Health and Human
Services, and conducted by the OAI Study Investigators. Private funding partners
include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research
Zhang et al. BMC Musculoskeletal Disorders 2014, 15:264 Page 8 of 9
http://www.biomedcentral.com/1471-2474/15/264Laboratories; and GlaxoSmithKline. Private sector funding for the OAI is managed
by the Foundation for the National Institutes of Health.
There were 82 knees are from the progression subcohort having kindly
been provided for public access by iMorphics (performed these image
segmentations). Thanks John Lynch and Felix Liu for giving us the images.
Jeffrey Duryea contributed to the JSW and HKA data.
Author details
1Division of Rheumatology, Tufts Medical Center, 800 Washington Street, Box
#406, Boston, MA 02111, USA. 2The Institute for Clinical Research and Health
Policy Studies, Tufts Medical Center, and Tufts Clinical and Translational
Science Institute, Tufts University, 800 Washington Street, Box #63, Boston,
MA 02111, USA. 3Medical Care Line and Research Care Line; Houston Health
Services Research and Development (HSR&D), Center of Excellence Michael E.
DeBakey VAMC, Houston, TX, USA. 4Section of Immunology, Allergy, and
Rheumatology, Baylor College of Medicine, Houston, TX. 1 Baylor Plaza,
BCM-285, Houston, TX 77030, USA. 5Department of Electrical and Computer
Engineering, Tufts University, 216 Halligan Hall, Medford, MA 02155, USA.
6Department of Radiology, Tufts Medical Center, 800 Washington Street, Box
#299, Boston, MA 02111, USA.
Received: 7 May 2014 Accepted: 25 July 2014
Published: 6 August 2014References
1. Roemer FW, Crema MD, Trattnig S, Guermazi A: Advances in imaging of
osteoarthritis and cartilage. Radiology 2011, 260:332–354.
2. Eckstein F, Wirth W: Quantitative cartilage imaging in knee osteoarthritis.
Arthritis 2011, 2011:1–19.
3. Frobell RB, Le Graverand MP, Buck R, Roos EM, Roos HP, Tamez-Pena J,
Totterman S, Lohmander LS: The acutely ACL injured knee assessed by
MRI: changes in joint fluid, bone marrow lesions, and cartilage during
the first year. Osteoarthritis Cartilage 2009, 17:161–167.
4. Eckstein F, Hudelmaier M, Wirth W, Kiefer B, Jackson R, Yu J, Eaton CB,
Schneider E: Double echo steady state magnetic resonance imaging of
knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis
Initiative. Ann Rheum Dis 2006, 65:433–441.
5. Hernandez-Molina G, Guermazi A, Niu J, Gale D, Goggins J, Amin S, Felson
DT: Central bone marrow lesions in symptomatic knee osteoarthritis and
their relationship to anterior cruciate ligament tears and cartilage loss.
Arthritis Rheum 2008, 58:130–136.
6. Felson DT, Nevitt MC, Yang M, Clancy M, Niu J, Torner JC, Lewis CE,
Aliabadi P, Sack B, Mcculloch C, Zhang Y: A new approach yields high
rates of radiographic progression in knee osteoarthritis. J Rheumatol
2008, 34:2047–2054.
7. Jaremko JL, Cheng RW, Lambert RG, Habib AF, Ronsky JL: Reliability of an
efficient MRI-based method for estimation of knee cartilage volume
using surface registration. Osteoarthritis Cartilage 2006, 14:914–922.
8. Steines D, Lang P: U.S. Patent 6,799,066. In Book U.S. Patent 6,799,066. USA:
United States Patent; 2004.
9. Wirth W, Nevitt M, Hellio Le Graverand MP, Benichou O, Dreher D, Davies R,
Lee J, Picha K, Gimona A, Maschek S, Hudelmaier M, Eckstein F, OAI
investigators: Sensitivity to change of cartilage morphometry using
coronal FLASH, sagittal DESS, and coronal MPR DESS protocols–comparative
data from the Osteoarthritis Initiative (OAI. Osteoarthritis Cartilage 2009,
18:547–554.
10. Duryea J, Ratzlaff C, Iranpour-Boroujeni T, Collins J, Losina E, Vanwynngaarden C,
Gu A: Responsiveness of a semi-automated novel method of measuring
cartilage loss in knee osteoarthritis over two years using 3.0 T Dess 3D MRI.
Osteoarthritis Cartilage 2012, 20:S54–S296.
11. Cashman PMM, Kitney RI, Gariba MA, Carter ME: Automated techniques for
visualization and mapping of articular cartilage in MR images of the
osteoarthritic knee: a base technique for the assessment of
microdamage and submicro damage. Trans NanoBioscience 2002, 1:42–51.
12. Hussain ZT, Usha SS: Automated image processing and analysis of
cartilage MRI: enabling technology for data mining applied to
osteoarthritis. In AIP Conference Proceedings. 2007:262–276.
13. Vincent G, Wolstenholme C, Scott I, Bowes M: Fully Automatic
Segmentation of the Knee Joint using Active Appearance Models. In
Medical Image Analysis for the Clinic: A Grand Challenge. 2010.14. Yin Y, Zhang X, Williams R, Wu X, Anderson D, Sonka M: LOGISMOS - Layered
Optimal Graph Image Segmentation of Multiple Objects and Surfaces:
cartilage segmentation in the knee joint. IEEE Trans Med Imaging 2010,
29:2023–2037.
15. Fripp J, Crozier S, Warfield S, Ourselin S: Automatic segmentation and
quantitative analysis of the articular cartilages from magnetic resonance
images of the knee. IEEE Trans Med Imaging 2010, 29:55–64.
16. Arno S, Walker PS, Bell CP, Krasnokutsky S, Samuels J, Abramson SB, Regatte R,
Recht M: Relation between cartilage volume and meniscal contact in medial
osteoarthritis of the knee. Knee 2012, 19:896–901.
17. Bae WC, Payanal MM, Chen AC, Hsieh-Bonassera ND, Ballard BL, Lotz MK,
Coutts RD, Bugbee WD, Sah RL: Topographic patterns of cartilage lesions
in knee osteoarthritis. Cartilage 2010, 1:10–19.
18. Bennett LD, Buckland-Wright JC: Meniscal and articular cartilage changes
in knee osteoarthritis: a cross-sectional double-contrast macroradiographic
study. Rheumatology 2002, 41:917–923.
19. Sharma L, Song J, Dunlop D, Felson D, Lewis CE, Segal N, Torner J, Cooke
TD, Hietpas J, Lynch J, Nevitt M: Varus and valgus alignment and incident
and progressive knee osteoarthritis. Ann Rheum Dis 2010, 69:1940–1945.
20. McAlindon T, LaValley M, Schneider E, Nuite M, Le J, Price L, Lo G,
Dawson-Hughes B: Effect of vitamin D supplementation on progression of
knee pain and cartilage volume loss in patients with symptomatic
osteoarthritis: a randomized controlled trial. JAMA 2012, 309:155–162.
21. Peterfy CG, Schneider E, Nevitt M: The osteoarthritis initiative: report on
the design rationale for the magnetic resonance imaging protocol for
the knee. Osteoarthritis Cartilage 2008, 16:1433–1441.
22. Patrick ES, Joseph LF: Intraclass correlations: uses in assessing rater
reliability. Psychol Bull 1979, 86:420–428.
23. Eckstein F, Wirth W, Hudelmaier M, Stein V, Lengfelder V, Cahue S,
Marshall M, Prasad P, Sharma L: Patterns of femorotibial cartilage loss
in knees with neutral, varus, and valgus alignment. Arthritis Rheum
2008, 59:1563–1570.
24. Pelletier J-P, Raynauld J-P, Berthiaume M-J, Abram F, Choquette D, Haraoui B,
Beary JF, Cline GA, Meyer JM, Martel-Pelletier J: Risk factors associated with
the loss of cartilage volume on weight-bearing areas in knee osteoarthritis
patients assessed by quantitative magnetic resonance imaging: a longitudinal
study. Arthritis Res Ther 2007, 9:R74.
25. Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G: Knee cartilage
defects: association with early radiographic osteoarthritis, decreased
cartilage volume, increased joint surface area and type II collagen
breakdown. Osteoarthritis Cartilage 2005, 13:198–205.
26. Eckstein F, Wirth W, Hunter DJ, Guermazi A, Kwoh CK, Nelson DR, Benichou
O: Magnitude and regional distribution of cartilage loss associated with
grades of joint space narrowing in radiographic osteoarthritis–data from
the Osteoarthritis Initiative (OAI). Osteoarthritis Cartilage 2010, 18:760–768.
27. Hunter DJ, Zhang W, Conaghan PG, Hirko K, Menashe L, Li L, Reichmann
WM, Losina E: Systematic review of the concurrent and predictive validity
of MRI biomarkers in OA. Osteoarthritis Cartilage 2011, 19:557–588.
28. Duryea J, Zaim S, Genant HK: New radiographic-based surrogate outcome
measures for osteoarthritis of the knee. Osteoarthritis Cartilage 2003,
11:102–110.
29. Neumann G, Hunter D, Nevitt M, Chibnik LB, Kwoh K, Chen H, Harris T,
Satterfield S, Duryea J, Study HA: Location specific radiographic joint
space width for osteoarthritis progression. Osteoarthritis Cartilage 2009,
17:761–765.
30. Duryea J, Neumann G, Niu J, Totterman S, Tamez J, Dabrowski C, Graverand
MPL, Luchi M, Beals CR, Hunter DJ: Comparison of radiographic joint
space width with magnetic resonance imaging cartilage morphometry:
analysis of longitudinal data from the Osteoarthritis Initiative. Arthritis
Care Res 2010, 62:932–937.
31. Altman RD, Gold GE: tlas of individual radiographic features in
osteoarthritis, revised. Osteoarthritis Cartilage 2007, 15 Suppl A:A1–56.
32. Sharma L, Song J, Felson TD, Cahue S, Shamiyeh E, Dunlop DD: The role of
knee alignment in disease progression and functional decline in knee
osteoarthritis. JAMA 2001, 286:188–195.
33. Cicuttini F, Wluka A, Hankin J, Wang Y: Longitudinal study of the
relationship between knee angle and tibiofemoral cartilage volume in
subjects withknee osteoarthritis. Rheumatol 2004, 43:321–324.
34. Iranpour-Boroujeni T, Watanabe A, Bashtar R, Yoshioka H, Duryea J:
Quantification of cartilage loss in local regions of knee joints using
semi-automated segmentation software: analysis of longitudinal data
Zhang et al. BMC Musculoskeletal Disorders 2014, 15:264 Page 9 of 9
http://www.biomedcentral.com/1471-2474/15/264from the Osteoarthritis Initiative (OAI). Osteoarthritis Cartilage 2011,
19:309–314.
35. Chan WP, Huang G-S, Hsu S-M, Chang Y-C, Ho W-P: Radiographic joint
space narrowing in osteoarthritis of the knee: relationship to meniscal
tears and duration of pain. Skeletal Radiol 2008, 37:917–922.
36. Beattie KA, Duryea J, Pui M, O’Neill J, Boulos P, Webber CE, Eckstein F,
Adachi JD: Minimum joint space width and tibial cartilage morphology
in the knees of healthy individuals: A cross-sectional study. BMC
Musculoskelet Disord 2008, 9:119.
37. Hunter D, Buck R, Vignon E, Eckstein F, Brandt K, Mazzuca SA, Wyman BT,
Otterness I, Hellio Le Graverand MP: Relation of regional articular cartilage
morphometry and meniscal position by MRI to joint space width in
kneeradiographs. Osteoarthritis Cartilage 2009, 17:1170–1176.
38. Hunter DJ, Zhang W, Conaghan PG, Hirko K, Menashe L, Reichmann WM,
Losina E: Responsiveness and reliability of MRI in knee osteoarthritis:
a meta-analysis of published evidence. Osteoarthritis Cartilage 2011,
19:589–605.
39. Moriya S, Miki Y, Matsuno Y, Okada M: Three-dimensional double-echo
steady-state (3D-DESS) magnetic resonance imaging of the knee:
establishment of flip angles for evaluation of cartilage at 1.5 T and 3.0 T.
Acta Radiol 2012, 53:790–794.
40. Roemer FW, Kwoh CK, Hannon MJ, Crema MD, Moore CE, Jakicic JM, Green
SM, Guermazia A: Semiquantitative assessment of focal cartilage damage
at 3 T MRI: A comparative study of dual echo at steady state (DESS) and
intermediate-weighted (IW) fat suppressed fast spin echo sequences.
Eur J Radiol 2011, 80:e126–e131.
41. Bloecker K, Wirth W, Hunter DJ, Duryea J, Guermazi A, Kwoh CK, Resch H,
Eckstein F: Contribution of regional 3D meniscus and cartilage
morphometry by MRI to joint space width in fixed flexion knee
radiography–a between-knee comparison in subjects with unilateral
joint space narrowing. Eur J Radiol 2013, 82:e832–839.
42. Wirth W, Nevitt M, Hellio Le Graverand MP, Lynch J, Maschek S, Hudelmaier M,
Eckstein F, Group ftOII: Lateral and medial joint space narrowing predict
subsequent cartilage loss in the narrowed, but not in the non-narrowed
femorotibial compartment - data from the Osteoarthritis Initiative.
Osteoarthritis Cartilage 2013, S1063–4584:00984–00989.
43. Eckstein F, Maschek S, Maschek S: One year change of knee cartilage
morphology in the first release of participants from the Osteoarthritis
Initiative progression subcohort: association with sex, body mass index,
symptoms and radiographic osteoarthritis status. Ann Rheum Dis 2009,
68:674–679.
44. Bloecker K, Guermazi A, Wirth W, Benichou O, Kwoh CK, Hunter DJ, Englund M,
Resch H, Eckstein F, OAI investigators: Tibial coverage, meniscus position,
size and damage in knees discordant for joint space narrowing - data from
the Osteoarthritis Initiative. Osteoarthritis Cartilage 2013, 21:419–427.
doi:10.1186/1471-2474-15-264
Cite this article as: Zhang et al.: Development of a rapid knee cartilage
damage quantification method using magnetic resonance images.
BMC Musculoskeletal Disorders 2014 15:264.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
